9999999997-15-000165.txt : 20150113 9999999997-15-000165.hdr.sgml : 20150113 20150113141810 ACCESSION NUMBER: 9999999997-15-000165 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150113 DATE AS OF CHANGE: 20150113 20150113 20150113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AmpliPhi Biosciences Corp CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 333-193458 FILM NUMBER: 15524479 BUSINESS ADDRESS: STREET 1: 4870 SADLER ROAD STREET 2: SUITE 300 CITY: GLEN ALLEN STATE: VA ZIP: 23060 BUSINESS PHONE: 650-888-2422 MAIL ADDRESS: STREET 1: 4870 SADLER ROAD STREET 2: SUITE 300 CITY: GLEN ALLEN STATE: VA ZIP: 23060 FORMER COMPANY: FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/ DATE OF NAME CHANGE: 19940331 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0R(#`@;V)J#3P\+TQI;F5AF4@-34O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1(()-@U@,0G4P8F1H:=(%D&1G3B/^.L/P`!!@"S9`;D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HU-"`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``*>8@94P,@` MDN5H0!9C@6(&AAL,W`R7!E+U!A9V4^/@UE;F1O8FH--#4@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I;ORH9,4*X M(3/X].N$\T!2VA1C80V^5*DN%MY]G'O7.MFK@QN)B\IH4]KR0`Q)NF3E"OMG M;`\Y_=KV:^\/.8ZHC'Q(JF\`^E-%A&#XU/#4?7-TQ,.?0-RYSN"JAA=(P2WI M(3TNX4MWP2&K)PC$($+UG10C`AY`UG,P3B>D]YG!AIL#FTK1+WU3C6N"&IAU M]B[?Z`$Z.J0QP@GB2$3`C40(20=F',CZ$1D#QB>?+[IO*J(\IKV6GA5?:D\)ZKN>)_UES% M!OD$10$?MZ.KG*BS)3?,IJOA`;.;"KYWI^)[X.\% M?$&:^[Q8<562!C%!I>U5,:AC)$#QO1+^'A_ZI3A><4_&BJMZTXL+N47`Y?R6X7A%>"6YJS]#;B(%)8.M)&`-O.Z6W2LM]O>6O]59%1S0& M;-3_?6.$FCV.Y6/[D^/UO>P=DE0`?/N/Y?88O-P>AY/;WP(,`+D'?&0-"F5N M9'-TSQ\WD-GQ>#T M@WC[]O1Z?'4N0O'NW=GY6`Q.Q[>AF#_!@GB:5X/3H@B%$L7]0&D1A+`,OWDH MLG`H\U04ZX$G_.+O02AU#"^+A7F^N$99C7QEY0>T,U!2):_OUG9W*,,P$L4< M5//L6:A8AJH1<.=]]!-O`O]7OO:*BW.8B5L_4%XQ@FEQ<>O_6;P?A"@DQ/.9 MS(>'+(U:EH:AIG,\>0:ML04^T(R6:8,83:_.*;LV+\.ZY<^\$0!LW'Z20-]$@[)CUG]KL06QN@#C[M@H_\5:%,HK:[([1Y[0/.6[1M57[P5>0]X+P49QB&Y0:@ MYR`D.;$%,$:!J8PRMOW.FYWXG,D[MT0V2>5K[ MD5?2@8KV1DC_0TG)9;T@DW%V#!C5)+%49GD;ADM?*5:]PF$)UH@)^+V1(HKX MPA(9VEL*.&-&D7E6>10G0UQDQ;PADDGG6A$],('1P\FSN/,`'Y5[ES_U2=TH MB\(DS_"\ELEA-'03YW"^S9._]OTU]KZ0Y'(HE`_%Y0-E9AS[T0$;7.H*K?IS M5V%>L#&RUS\"O-=;G_D'^#_X3+_D7>EL8IJ*J)WBVBVUVY`2BP$GJYHW&Y7;M<SA0+LQ.7*C+*A8B_K!O(-CI$G+W&47DD+$ MF.%0HZNBQH,"U8I+?^A,78L>+P(-L.M61-PR)9.T&](O8&^B_,Y3J(M1AWQ& M^)8$.*[U7*=U6D-_#*+@`$-:KAP"[D3/8BCV0`E%O*IV4V)2D'E??1UZ0BLJ M^L29^(3X2-2EV=J2B@FX8/))2B&)U-G!'-+T"CJ5*CV:4EVS4/QLMCBXSOS, M=B/0&O9JB M'@U_FR/61%-41NCP2Q?<3-S*J+1)V.QJF?M*+MB9B36`1#8!W[L%8!,6Y=0P M!=L*)-"&N"TV]Y14D0M7V*Y4^+QQS%KO8Y`8^9RH:?$$FN*/L"!O$2%)-RM% MDNA/'@B8??)AI&E,TQ-61DV;H*R.9-Y>/*U03`UL3SC/(6AE:W^#8[ZW+M3E`E MPO<4:(M^%ZF@T>RWH+T&GIH>ZOXAU\T)#&KC[PVC@9,+?/>F)SN6T.L=JB3- M9U<$W>CQYGSX6B5Y_>$.OKM4_P:'3!K\U%%#T[G'6JRZQ5C'W+*$4G=XHV0V/.;'*XCD#8)'"[$.7\!WJ.%N-TLM:N'7B"D% M5)SPWZ3P[NT/I7)!?-(IRS7%[O^>)$\@O>$![MBGKG&PR<]V!_29!7>']K8R M`^4=TWV#1+KL:3O!V,2HXDZLW&)+LYP_DBO+&ODR-;U&H%5#!A,:D3S88>NT<05R MPU$"9,=OUV5.I7\X,-_X0#9=%(/_!!@`2L$&9`T*96YDCBY,HDP,"0FU=2Y![D&!D1&:7`?IZ!C8&9 M`0P2DXL+'`,"?$#LO/R\5`8,\.T:`R.(OJP+,@M3'B]@32XH*@'2!X#8*"6U M.!E(?P'BS/*2`J`X8P*0+9*4#6:#U(EDAP0Y`]D=0#9?26H%2(S!.;^@LB@S M/:-$P=#2TE+!,24_*54AN+*X)#6W6,$S+SF_J""_*+$D-06H%FH'"/"[%R56 M*K@GYN8F*ACI&9'H^2'Q*93_0GE51014DHD12):A*NR!<46$2D%1$FI0E14%P@`!%%375;$!=4UPH,'##,R)IK!1:J)`PY`#T=D M],0E,C$M)^(P3L@0B&MD%3$>1BA*$O`$IPAX4F)L\*3&X.`%-`EXH?0DX(6: M:1YH_AH!+\9``EY,D2XNW`T^O:"MVS1C[J;]F#,T_+VQSB_337XE[[;]8_[2 M#%`T=^Q?A^QVTW@Z+&W;OI]6JQEY"VMHF*TM(1I!(VJ4&I5&TEC`L[4EE,)* M8:6P4E@IK!16"BN%E2)*$:6(4D0IHA11BBA%E")*D85RYS:T5-W.[?)!/W!] M>GJ^+>8G,GFG%RU^WQ-&;WL6V.8_/TMAS[X:H9 M?BT_=??X;W;K^><:$G^O/G>/;9=W#PU$G[N_GJ9Y3T^!_/9'[D_3>7GZ_GP8 MV^%M.>3QSXT]+O)#_^(N,=JW[CZ/;Z35ZG^ZL^59%[BY\],^4@CG.]SH"\5; MMJIL5L6L!K,:S6II5BNSFLQJ;=MX1Y9MR]NZO.W+V\*\;G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@] M(F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`U+C(M M8S`P,2`V,RXQ,SDT,SDL(#(P,3`O,#DO,C&UP.DUE=&%D M871A1&%T93XR,#$U+3`Q+3$S5#$T.C$V.C4S+3`U.C`P/"]X;7`Z365T861A M=&%$871E/@H@("`@("`@("`\>&UP.D-R96%T;W)4;V]L/D%C&UP.D-R96%T;W)4;V]L/@H@("`@("`\ M+W)D9CI$97-C&UL;G,Z>&UP34T](FAT='`Z+R]N&%P+S$N,"]M;2\B/@H@("`@("`@("`\>&UP34TZ1&]C=6UE M;G1)1#YU=6ED.C4W-F1E-#DP+38W960M-#4X9BTX-S$V+6(X9#(S-&,T-3$V M.#PO>&UP34TZ1&]C=6UE;G1)1#X*("`@("`@("`@/'AM<$U-.DEN&UL M;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N M8V]M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI02`Q,"XP/"]P9&8Z4')O9'5C97(^"B`@("`@(#PO7!E+T]B:E-T;3X^J'5!:DZ@HD`YI:G6@K%V6"FN%.,<*%W4Y5?5$JOTGP`!`+D[S#0IE;F1S=')E86T-96YD;V)J#34@,"!O8FH-/#PO1&5C M;V1E4&%R;7,\/"]#;VQU;6YS(#0O4')E9&EC=&]R(#$R/CXO1FEL=&5R+T9L M871E1&5C;V1E+TE$6SQ$03DX039&-#8Y049$.#1#030P-D5!-#E$.48R,S5% M,CX\0S=$,T,S.34U13`Q0S7!E+UA2968O M5ULQ(#(@,5T^/G-T